Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bixia Tang

Showing results (31-40 of 114) with videos related to

Pageof 12
Sort By:
Nucleic Acids Research|December 8, 2025
Genome Variation Map: a platform for the analysis and integration of genomic variationXue Bai, Haixia Xie, Hong Luo, et al.
Zhonghua Yi Xue Za Zhi|December 30, 2015
[Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma]Bixia Tang, Zhihong Chi, Xinan Sheng, et al.
Annals of Surgical Oncology|December 23, 2017
Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in ChinaSiming Li, Xinan Sheng, Lu Si, et al.
World Journal of Urology|April 2, 2025
A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapySiming Li, Jinchang Wei, Huayan Xu, et al.
Genomics, Proteomics & Bioinformatics|June 24, 2024
GenBase: A Nucleotide Sequence DatabaseCongfan Bu, Xinchang Zheng, Xuetong Zhao, et al.
The British Journal of Ophthalmology|January 18, 2015
Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patientsXinan Sheng, Siming Li, Zhihong Chi, et al.
Nucleic Acids Research|November 17, 2025
EWAS Open Platform 2026: a deeply integrated resource for epigenome-wide association studiesFei Yang, Zhuang Xiong, Wenting Zong, et al.
BMC Medicine|July 2, 2026
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 studyJuan Li, Huichun Tian, Huayan Xu, et al.
Nucleic Acids Research|November 11, 2024
iDog: a multi-omics resource for canids studyYanhu Liu, Yibo Wang, Jiani Sun, et al.
Frontiers in Immunology|July 22, 2021
Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical TrialsLi Zhou, Xuan Wang, Zhihong Chi, et al.
Pageof 12

Showing results (31-40 of 114) with videos related to

Sort By:
Pageof 12
Nucleic Acids Research|December 8, 2025
Genome Variation Map: a platform for the analysis and integration of genomic variationXue Bai, Haixia Xie, Hong Luo, et al.
Zhonghua Yi Xue Za Zhi|December 30, 2015
[Efficacy and safety of sorafenib in patients with advanced renal cell carcinoma]Bixia Tang, Zhihong Chi, Xinan Sheng, et al.
Annals of Surgical Oncology|December 23, 2017
Outcomes and Predictive Factors of Isolated Limb Infusion for Patients with In-transit Melanoma in ChinaSiming Li, Xinan Sheng, Lu Si, et al.
World Journal of Urology|April 2, 2025
A prognostic model for survival of patients with metastatic upper tract urothelial carcinoma with first-line systemic therapySiming Li, Jinchang Wei, Huayan Xu, et al.
Genomics, Proteomics & Bioinformatics|June 24, 2024
GenBase: A Nucleotide Sequence DatabaseCongfan Bu, Xinchang Zheng, Xuetong Zhao, et al.
The British Journal of Ophthalmology|January 18, 2015
Prognostic factors for conjunctival melanoma: a study in ethnic Chinese patientsXinan Sheng, Siming Li, Zhihong Chi, et al.
Nucleic Acids Research|November 17, 2025
EWAS Open Platform 2026: a deeply integrated resource for epigenome-wide association studiesFei Yang, Zhuang Xiong, Wenting Zong, et al.
BMC Medicine|July 2, 2026
Evaluation and analysis of renal injury in patients with advanced renal cell carcinoma receiving first-line benmelstobart plus anlotinib: results from the ETER100 studyJuan Li, Huichun Tian, Huayan Xu, et al.
Nucleic Acids Research|November 11, 2024
iDog: a multi-omics resource for canids studyYanhu Liu, Yibo Wang, Jiani Sun, et al.
Frontiers in Immunology|July 22, 2021
Association of NRAS Mutation With Clinical Outcomes of Anti-PD-1 Monotherapy in Advanced Melanoma: A Pooled Analysis of Four Asian Clinical TrialsLi Zhou, Xuan Wang, Zhihong Chi, et al.
Pageof 12